Skip to main content
. 2019 Jan 16;7:12. doi: 10.1186/s40425-018-0459-y

Fig. 4.

Fig. 4

Best change in sum of target lesion diameters from baseline (a), and PFS (b) and OS (c) according to tumor PD-L1 expression status at 1% cutoff in evaluable patients